Keyphrases
Latent Tuberculosis
100%
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Latent Tuberculosis Infection
50%
Randomized Controlled Trial
16%
Treatment Efficacy
16%
Treatment Effect
16%
Retrospective Cohort Study
16%
Inclusion Criteria
16%
Embase
16%
PubMed
16%
Prospective Cohort Study
16%
Preventive Measures
16%
Mycobacterium Tuberculosis (M. tb)
16%
Cochrane Library
16%
Global Spread
16%
Active Tuberculosis
16%
Tailored Treatment
16%
People at Risk
16%
Routine Clinical Data
16%
Rifampicin
16%
TB in children
16%
TB Control
16%
TB Control Program
16%
Medicine and Dentistry
Systematic Review
100%
Latent Tuberculosis
100%
Multidrug Resistant Tuberculosis
100%
Isoniazid
50%
Tuberculosis
50%
Randomized Controlled Trial
16%
Retrospective Cohort Study
16%
Observational Study
16%
Prospective Cohort Study
16%
Mycobacterium Tuberculosis
16%
Rifampicin
16%
Nursing and Health Professions
Systematic Review
100%
Latent Tuberculosis
100%
Multi-Drug-Resistant Tuberculosis
100%
Isoniazid
50%
Tuberculosis
50%
Medline
16%
Cohort Analysis
16%
Cochrane Library
16%
Prospective Cohort Study
16%
Rifampicin
16%
Drug Resistant Tuberculosis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Latent Tuberculosis
100%
Multi-Drug-Resistant Tuberculosis
100%
Isoniazid
50%
Tuberculosis
50%
Randomized Controlled Trial
16%
Cohort Study
16%
Observational Study
16%
Prospective Cohort Study
16%
Mycobacterium Tuberculosis
16%
Rifampicin
16%
Neuroscience
Multi-Drug-Resistant Tuberculosis
100%
Isoniazid
50%
Randomized Controlled Trial
16%
Rifampicin
16%